Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 489341 - 489360 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FE03) necitumumab | PORTRAZZA 800MG/50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EliLilly&Company |
| USA | (L01FE03) necitumumab | PORTRAZZA 800MG/50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EliLilly&Company |
| USA | (L01FF01) nivolumab | OPDIVO 100MG/10ML INJ | 1X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 10MG/ML INJ,SOLN 24ML | 24ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 120MG VIAL | 12ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 40MG/4ML INJ | 1X4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF04) avelumab | BAVENCIO (AVELUMAB) INJECTION 20MG/ML | 1X10VI | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | EMDSerono,Inc. |
| USA | (L01FF04) avelumab | BAVENCIO (AVELUMAB) INJECTION 20MG/ML | 1X10VI | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | EMDSerono,Inc. |
| USA | (L01FF05) atezolizumab | TECENTRIQ/1200MG/20ML(60MG/ML)SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab | TECENTRIQ/1200MG/20ML(60MG/ML)SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab | TECENTRIQ 840MG/14ML(60MG/ML)SDV | 14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab | TECENTRIQ 840MG/14ML(60MG/ML)SDV | 14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF06) cemiplimab | LIBTAYO 50MG/ML INJ,VIL,7ML | 1X7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronPharmaceuticals,Inc. |
| USA | (L01FF06) cemiplimab | LIBTAYO 50MG/ML INJ,VIL,7ML | 1X7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronPharmaceuticals,Inc. |
| USA | (L01FF07) dostarlimab | JEMPERLI 50MG/ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKline |
| USA | (L01FF07) dostarlimab | JEMPERLI 50MG/ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKline |
| USA | (L01FG01) bevacizumab | AVASTIN 25MG/ML INJ | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | GenentechUSA,Inc. |
| USA | (L01FG01) bevacizumab | AVASTIN 25MG/ML INJ | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | GenentechUSA,Inc. |
| USA | (L01FG01) bevacizumab | AVASTIN 25MG/ML INJ | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | GenentechUSA,Inc. |
| USA | (L01FG01) bevacizumab | AVASTIN 25MG/ML INJ | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | GenentechUSA,Inc. |
Pages
